Coller Capital

Zepz is an online money transfer service that enables individuals to send money to friends and family living abroad through computers, smartphones, or tablets. It provides a convenient and cost-effective alternative to traditional money transfer companies, which often charge high fees. Zepz allows users to send funds to over 140 destinations worldwide, including Europe, Asia, Africa, Australia, and the Americas. Recipients can receive money as bank deposits, cash pickups, Mobile Money, or mobile airtime top-ups. The platform is designed to facilitate secure international transfers, utilizing technology that allows customers to manage their funds efficiently, with lower processing fees compared to conventional methods. Zepz operates in 50 countries, aiming to simplify the process of remittance for its users.

IntelePeer is a communications automation platform that utilizes generative AI to enhance customer interactions for businesses. By offering a cloud-based Communications Platform as a Service (CPaaS), the company provides on-demand IP communications and SIP trunking services tailored for enterprises. IntelePeer's platform integrates seamlessly with existing systems, allowing businesses to streamline their communication processes across multiple channels. Its focus on automation not only reduces operational costs but also improves customer experience by delivering efficient and effective communication solutions. The incorporation of AI and analytics further enhances the platform's capabilities, enabling clients to achieve higher levels of customer satisfaction and engagement.

Ssangyong C&E is a private cement manufacturing company, established in South Korea. It produces and sells a range of cement products, including Portland cement, blended cement, specialty cement, and mortar, from its manufacturing facilities in Donghae and Yeonwol. The company is also involved in waste recycling and environmental businesses, demonstrating a commitment to sustainability. Notably, Ssangyong C&E has pioneered technological advancements in the local cement industry through its independent technology research center.

Exterro, Inc. is a provider of e-discovery and information governance software solutions focused on the legal and IT markets, serving Fortune 500 corporations as well as law firms and government agencies. Founded in 2004 and headquartered in Beaverton, Oregon, the company offers the Fusion Platform, which integrates with existing enterprise technologies to connect stakeholders such as legal, IT, records management, and compliance teams. Exterro’s solutions include E-Discovery Data Mapping for creating data maps of electronically stored information, Legal Hold for compliance with privacy laws, and E-Discovery Data Management for collection and review processes. Additionally, it provides project management tools for legal teams, a case law library for reference, and cloud-based e-discovery software. The company's offerings aim to enhance collaboration, mitigate risks, and streamline legal processes, thereby enabling organizations to better manage governance, risk, and compliance challenges.

Hoxton Farms, located in London, UK, specializes in producing real animal fat without the use of animals. The company employs a combination of cell biology and mathematical modeling to cultivate purified animal fat in bioreactors. This innovative approach provides a sustainable and cruelty-free ingredient for the meat alternatives industry, as well as applications in other sectors such as bakery, confectionery, and cosmetics. By focusing on cultivated fat, Hoxton Farms aims to meet the growing demand for ethical and environmentally friendly food products.

Book A Tiger is a technology-driven company that specializes in integrated facility management. It offers high-quality cleaning services to customers, with the added convenience of online booking. Furthermore, the company extends its service offerings through a connected network of partner providers, catering to a broader range of facility management needs.

uniQure is a pioneering gene therapy company recognized for developing the first gene therapy product to receive regulatory approval in the European Union. Its initial product, Glybera, was authorized in October 2012 for treating patients with lipoprotein lipase deficiency, a rare and severe metabolic disorder. uniQure specializes in creating innovative gene therapies that offer long-term and potentially curative benefits for genetic and acquired diseases. The company utilizes a modular technology platform and a proprietary manufacturing process to develop its treatments. Currently, uniQure is expanding its pipeline of adeno-associated virus (AAV)-based gene therapies, focusing on conditions such as hemophilia, Huntington's disease, and cardiovascular diseases through collaborations, including one with Bristol Myers Squibb. While the company initially targets orphan diseases, it also aims to address chronic and degenerative diseases affecting larger populations.

Societe Innovatech du Grand Montreal